United Kingdom · Funded startup

Who invested in Akari Therapeutics

2 rounds we have observed, with the 7 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 1 Nov 2026

$88Mraised across 2 rounds since 2013, from 2 sources

$13MGrowth$75MRound
Latest round
Round, $75MSept 2015
Step-upi
6×
Investors
7
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20142015
$13MGrowth$75MRound
First round
Growth, $13M
Oct 2013
Biggest round
$75M
Round · Sept 2015
Between rounds
2 years
from the last two

The rounds

  1. Sept 2015
    Round$75M7 new

    From a historical funding recordSEC filing: $75M sold, first sale Sept 2015

  2. Oct 2013
    Growth$13M

    No investor was named in the report.

    Reported by biospace.com

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

VenrockVC firm1round
RA Capital ManagementPrivate equity1round
DeerfieldVC firm1round
Vivo CapitalPrivate equity1round
Foresite CapitalPrivate equity1round
QVT Financial LPFamily office1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Akari Therapeutics

Who invested in Akari Therapeutics?

Akari Therapeutics's investors include New Enterprise Associates, Venrock, RA Capital Management, Deerfield and Vivo Capital, and 2 more on record.

How much has Akari Therapeutics raised?

Akari Therapeutics has raised $88M across 2 rounds since 2013.

When did Akari Therapeutics last raise?

Akari Therapeutics's most recent round was an Undisclosed round of $75M in Sept 2015.

What was Akari Therapeutics's biggest round?

Its most recent round, $75M in Sept 2015, is also its largest on record.

Who backed Akari Therapeutics first?

Akari Therapeutics's first round on record, in Sept 2015, was backed by New Enterprise Associates, Venrock and RA Capital Management and 4 others.

What stage is Akari Therapeutics at?

Akari Therapeutics's latest named round is an Undisclosed round, in Sept 2015.

Where is Akari Therapeutics based?

Akari Therapeutics is based in the United Kingdom.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.